GEORGE CHOLANKERIL to Treatment Outcome
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Treatment Outcome.
Connection Strength
0.479
-
Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy. Liver Transpl. 2026 Jun 01; 32(6):823-829.
Score: 0.077
-
Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139.
Score: 0.048
-
Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349.
Score: 0.044
-
Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453.
Score: 0.044
-
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922.
Score: 0.043
-
Portomesenteric venous thrombosis complicated by a haemorrhagic shock: a rare complication of laparoscopic gastrectomy. BMJ Case Rep. 2017 May 29; 2017.
Score: 0.043
-
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease. Liver Transpl. 2026 Jan 01; 32(1):86-94.
Score: 0.019
-
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Liver Transpl. 2025 May 01; 31(5):596-615.
Score: 0.018
-
Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
Score: 0.018
-
Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review. Saudi J Gastroenterol. 2024 01 01; 30(1):14-22.
Score: 0.017
-
Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
Score: 0.016
-
Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002.
Score: 0.012
-
Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410.
Score: 0.012
-
Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90.
Score: 0.012
-
Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653.
Score: 0.011
-
Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017 Oct 13; 9(10).
Score: 0.011
-
Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017 Oct; 29(10):1109-1117.
Score: 0.011
-
Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Oct; 112(10):1495-1505.
Score: 0.011
-
Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States. Hepatology. 2017 07; 66(1):46-56.
Score: 0.011